InnoCan Pharma Corporation (CSE:INNO)

Canada · Delayed Price · Currency is CAD

6.75

-0.18 (-2.60%)

Mar 2, 2026, 9:51 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Other Operations	38.00K	109.00K	135.00K	-	-
Other Operations Growth	-65.14%	-19.26%	-	-	-
Online Sales	29.40M	13.55M	2.42M	-	-
Online Sales Growth	117.00%	458.91%	-	-	-
Pharmaceuticals	-	-	-	196.00K	8.00K
Pharmaceuticals Growth	-	-	-	2350.00%	-
Total	29.44M	13.66M	2.56M	196.00K	8.00K
Total Growth	115.55%	433.69%	1205.61%	2350.00%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	29.40M	13.55M	2.42M	34.00K	-
United States Growth	117.00%	460.53%	7008.82%	-	-
Rest of The World	38.00K	109.00K	59.00K	41.00K	8.00K
Rest of The World Growth	-65.14%	84.75%	43.90%	412.50%	-
United Kingdom	-	-	83.00K	-	-
France	-	-	-	61.00K	-
Poland	-	-	-	60.00K	-
Total	29.44M	13.66M	2.56M	196.00K	8.00K
Total Growth	115.55%	433.69%	1205.61%	2350.00%	-

Source: S&P Global Market Intelligence.